130 related articles for article (PubMed ID: 31213901)
1. DCZ0814 induces apoptosis and G0/G1 phase cell cycle arrest in myeloma by dual inhibition of mTORC1/2.
Kong Y; Li B; Chang S; Gao L; Xu Z; He W; Yang G; Xie B; Chen G; Hu L; Lu K; Wang Y; Wu X; Zhu W; Shi J
Cancer Manag Res; 2019; 11():4797-4808. PubMed ID: 31213901
[No Abstract] [Full Text] [Related]
2. Metformin induces autophagy and G0/G1 phase cell cycle arrest in myeloma by targeting the AMPK/mTORC1 and mTORC2 pathways.
Wang Y; Xu W; Yan Z; Zhao W; Mi J; Li J; Yan H
J Exp Clin Cancer Res; 2018 Mar; 37(1):63. PubMed ID: 29554968
[TBL] [Abstract][Full Text] [Related]
3. Dual inhibition of mTORC1/2 by DCZ0358 induces cytotoxicity in multiple myeloma and overcomes the protective effect of the bone marrow microenvironment.
Gao L; Li B; Yang G; Liu P; Lan X; Chang S; Tao Y; Xu Z; Xie B; Sun X; Wang Y; Hu L; Yu D; Xie Y; Bu W; Wu X; Zhu W; Shi J
Cancer Lett; 2018 May; 421():135-144. PubMed ID: 29428642
[TBL] [Abstract][Full Text] [Related]
4. Pterostilbene Inhibits Human Multiple Myeloma Cells via ERK1/2 and JNK Pathway In Vitro and In Vivo.
Xie B; Xu Z; Hu L; Chen G; Wei R; Yang G; Li B; Chang G; Sun X; Wu H; Zhang Y; Dai B; Tao Y; Shi J; Zhu W
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27869675
[TBL] [Abstract][Full Text] [Related]
5. N-Hydroxyphthalimide exhibits antitumor activity by suppressing mTOR signaling pathway in BT-20 and LoVo cells.
Wang M; Zhou A; An T; Kong L; Yu C; Liu J; Xia C; Zhou H; Li Y
J Exp Clin Cancer Res; 2016 Mar; 35():41. PubMed ID: 26940018
[TBL] [Abstract][Full Text] [Related]
6. Linalool induces cell cycle arrest and apoptosis in HepG2 cells through oxidative stress generation and modulation of Ras/MAPK and Akt/mTOR pathways.
Rodenak-Kladniew B; Castro A; Stärkel P; De Saeger C; García de Bravo M; Crespo R
Life Sci; 2018 Apr; 199():48-59. PubMed ID: 29510199
[TBL] [Abstract][Full Text] [Related]
7. The HDAC Inhibitor Quisinostat (JNJ-26481585) Supresses Hepatocellular Carcinoma alone and Synergistically in Combination with Sorafenib by G0/G1 phase arrest and Apoptosis induction.
He B; Dai L; Zhang X; Chen D; Wu J; Feng X; Zhang Y; Xie H; Zhou L; Wu J; Zheng S
Int J Biol Sci; 2018; 14(13):1845-1858. PubMed ID: 30443188
[TBL] [Abstract][Full Text] [Related]
8. 1,8-Cineole promotes G0/G1 cell cycle arrest and oxidative stress-induced senescence in HepG2 cells and sensitizes cells to anti-senescence drugs.
Rodenak-Kladniew B; Castro A; Stärkel P; Galle M; Crespo R
Life Sci; 2020 Feb; 243():117271. PubMed ID: 31926243
[TBL] [Abstract][Full Text] [Related]
9. Calmodulin antagonists induce cell cycle arrest and apoptosis in vitro and inhibit tumor growth in vivo in human multiple myeloma.
Yokokura S; Yurimoto S; Matsuoka A; Imataki O; Dobashi H; Bandoh S; Matsunaga T
BMC Cancer; 2014 Nov; 14():882. PubMed ID: 25424011
[TBL] [Abstract][Full Text] [Related]
10. Novel Small Molecular Compound AE-848 Potently Induces Human Multiple Myeloma Cell Apoptosis by Modulating the NF-κB and PI3K/Akt/mTOR Signaling Pathways.
Xu Y; Feng X; Zhou Q; Jiang W; Dai Y; Jiang Y; Liu X; Li S; Wang Y; Wang F; Li A; Zheng C
Onco Targets Ther; 2020; 13():13063-13075. PubMed ID: 33376355
[TBL] [Abstract][Full Text] [Related]
11. A novel silicone derivative of natural osalmid (DCZ0858) exerts anti-multiple myeloma activity by promoting cell apoptosis and inhibiting cell cycle and mTOR signaling.
Bu W; Li B; Feng L; Feng Q; Hu K; Xu Z; Wang Y; Xi M; Wang H; Yang G; Wu X; Zhu W; Shi J
Am J Transl Res; 2021; 13(10):11439-11449. PubMed ID: 34786070
[TBL] [Abstract][Full Text] [Related]
12. Luteoloside induces G
Zhou M; Shen S; Zhao X; Gong X
Biochem Biophys Res Commun; 2017 Dec; 494(1-2):263-269. PubMed ID: 29024631
[TBL] [Abstract][Full Text] [Related]
13. Metformin displays anti-myeloma activity and synergistic effect with dexamethasone in in vitro and in vivo xenograft models.
Zi FM; He JS; Li Y; Wu C; Yang L; Yang Y; Wang LJ; He DH; Zhao Y; Wu WJ; Zheng GF; Han XY; Huang H; Yi Q; Cai Z
Cancer Lett; 2015 Jan; 356(2 Pt B):443-53. PubMed ID: 25305450
[TBL] [Abstract][Full Text] [Related]
14. Enhanced anticancer efficacy of snake venom combined with silica nanoparticles in a murine model of human multiple myeloma: molecular targets for cell cycle arrest and apoptosis induction.
Al-Sadoon MK; Rabah DM; Badr G
Cell Immunol; 2013; 284(1-2):129-38. PubMed ID: 23973876
[TBL] [Abstract][Full Text] [Related]
15. Targeting of mTORC1/2 by dihydroevocarpine induces cytotoxicity in acute myeloid leukemia.
Zhang S; Xiong Y; Zhang Y; Zhao H
J Cell Physiol; 2019 Aug; 234(8):13032-13041. PubMed ID: 30548613
[TBL] [Abstract][Full Text] [Related]
16. Anti-liver cancer effect and the mechanism of arsenic sulfide in vitro and in vivo.
Wang S; Zhang C; Li Y; Li P; Zhang D; Li C
Cancer Chemother Pharmacol; 2019 Mar; 83(3):519-530. PubMed ID: 30542770
[TBL] [Abstract][Full Text] [Related]
17. The Combination of Sorafenib and Everolimus Abrogates mTORC1 and mTORC2 upregulation in osteosarcoma preclinical models.
Pignochino Y; Dell'Aglio C; Basiricò M; Capozzi F; Soster M; Marchiò S; Bruno S; Gammaitoni L; Sangiolo D; Torchiaro E; D'Ambrosio L; Fagioli F; Ferrari S; Alberghini M; Picci P; Aglietta M; Grignani G
Clin Cancer Res; 2013 Apr; 19(8):2117-31. PubMed ID: 23434734
[TBL] [Abstract][Full Text] [Related]
18. PDK1 inhibitor GSK2334470 exerts antitumor activity in multiple myeloma and forms a novel multitargeted combination with dual mTORC1/C2 inhibitor PP242.
Yang C; Huang X; Liu H; Xiao F; Wei J; You L; Qian W
Oncotarget; 2017 Jun; 8(24):39185-39197. PubMed ID: 28402933
[TBL] [Abstract][Full Text] [Related]
19. Preclinical efficacy of dual mTORC1/2 inhibitor AZD8055 in renal cell carcinoma harboring a TFE3 gene fusion.
Kauffman EC; Lang M; Rais-Bahrami S; Gupta GN; Wei D; Yang Y; Sourbier C; Srinivasan R
BMC Cancer; 2019 Sep; 19(1):917. PubMed ID: 31519159
[TBL] [Abstract][Full Text] [Related]
20. Rafoxanide, an organohalogen drug, triggers apoptosis and cell cycle arrest in multiple myeloma by enhancing DNA damage responses and suppressing the p38 MAPK pathway.
Xiao W; Xu Z; Chang S; Li B; Yu D; Wu H; Xie Y; Wang Y; Xie B; Sun X; Kong Y; Lan X; Bu W; Chen G; Gao L; Wu X; Shi J; Zhu W
Cancer Lett; 2019 Mar; 444():45-59. PubMed ID: 30583070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
